Regeneron: Catching Another Wind
Source: SeekingAlpha
2026-04-27 10:20:40 ET
Our last article about Regeneron ( REGN ) seems awkwardly timed in hindsight, given we called for even more upside from their all-time high when not a month later they entered a slow-but-steep selloff, no doubt exacerbated by the onslaught of issues around approval delays, political pressure around drug pricing, and the exogenous market shock of the US tariff announcements:
Read the full article on Seeking Alpha
For further details see:
Regeneron: Catching Another Wind
Alnylam Pharmaceuticals Inc.
NASDAQ: ALNY
ALNY Trading
1.21% G/L:
$289.93 Last:
247,711 Volume:
$284.48 Open:
ALNY Latest News
June 03, 2026 04:45:00 pm
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
ALNY Stock Data
$42,146,950,218
131,611,785
0.16%
379
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
